Assessing glycemic and weight-lowering potential of oral semaglutide in type 2 diabetes compared to other GLP-1 receptor agonists in Indian context

被引：0
|
作者：
Singh, Awadhesh Kumar [1 ,2 ,3 ]
Chawla, Rajeev [4 ]
机构：
[1] GD Hosp & Diabet Inst, Kolkata 700013, West Bengal, India
[2] Horizon Multispecial Hosp, Kolkata, West Bengal, India
[3] Sun Valley Hosp & Diabet Res Ctr, Gauhati, Assam, India
[4] North Delhi Diabet Ctr, New Delhi, India
来源：
INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES | 2024年 / 44卷 / 02期
关键词：
ONCE-WEEKLY SEMAGLUTIDE; OPEN-LABEL; PHASE; 3A; CARDIOVASCULAR OUTCOMES; JAPANESE PATIENTS; ADD-ON; EFFICACY; SAFETY; DULAGLUTIDE; METFORMIN;
D O I：
10.1007/s13410-024-01337-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：211 / 215
页数：5
相关论文
共 50 条
  • [31] Should GLP-1 Receptor Agonists Be the First Line of Treatment for Type 2 Diabetes?
    Pratley, Richard E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (11) : 671 - 673
  • [32] A review of GLP-1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once-weekly agents
    Cornell, Susan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 : 17 - 27
  • [33] Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
    Nagahisa, Taichi
    Saisho, Yoshifumi
    DIABETES THERAPY, 2019, 10 (05) : 1733 - 1752
  • [34] Semaglutide (Ozempic) - Another Injectable GLP-1 Receptor Agonist for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1539): : 19 - 21
  • [35] A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes
    Neil Webb
    Michelle Orme
    Michal Witkowski
    Rie Nakanishi
    Jakob Langer
    Diabetes Therapy, 2018, 9 : 973 - 986
  • [36] Glycaemic and non-glycaemic efficacy of once-weekly GLP-1 receptor agonists in people with type 2 diabetes
    Patel, Dhiren
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 : 28 - 42
  • [37] GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
    Neumiller, Joshua J.
    Alicic, Radica Z.
    Tuttle, Katherine R.
    KIDNEY AND DIALYSIS, 2022, 2 (03): : 386 - 398
  • [38] Efficacy and hypoglycemic risk of sitagliptin in obese/overweight patients with type 2 diabetes compared with GLP-1 receptor agonists A meta-analysis
    Dai, Danping
    Mao, Yiyang
    Jin, Haiying
    Zhang, Wei
    MEDICINE, 2019, 98 (36)
  • [39] SGLT-2 inhibitors and GLP-1 receptor agonists for Type 2 diabetes
    Davila, Esteban
    Mccormack, James
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (04) : 408 - 411
  • [40] GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective
    Rasalam, Roy
    Barlow, John
    Kennedy, Mark
    Phillips, Pat
    Wright, Alan
    DIABETES THERAPY, 2019, 10 (04) : 1205 - 1217
12345